Pricing Log in Create free account

Atrinsic Inc. (PTIX) vs Valion Bio, Inc. (VBIO)

Atrinsic Inc. and Valion Bio, Inc. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Valion Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.2×. Across the 11 metrics below, Atrinsic Inc. leads on 8 and Valion Bio, Inc. on 3.

Valuation

Metric PTIX VBIO Biotechnology median
P/E 0.24 n/m 10.60
P/S n/m 0.14 9.40
P/B 0.57 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 11.09 9.02
Earnings yield 412.96% (40,026.00%) (32.88%)
Free cash flow yield (220.47%) (22,510.36%) (23.13%)

Profitability

Metric PTIX VBIO Biotechnology median
Gross margin 0.00% (58.09%) 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (338.24%) (489.30%) (51.96%)
Return on assets 378.63% (104.96%) (46.06%)
Return on invested capital (229.86%) (61.01%) 0.00%

Growth

Metric PTIX VBIO Biotechnology median
Revenue growth (TTM) — (49.63%) 6.76%
EPS growth (last fiscal year) 188.24% 60.16% 29.88%
Revenue growth, 5-year CAGR — 13.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PTIX VBIO Biotechnology median
Debt to equity 0.00 0.62 0.00
Current ratio 0.66 1.11 4.97
Net debt to EBITDA 0.52 0.79 1.01

Dividend

Metric PTIX VBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PTIX VBIO Biotechnology median
Market cap 1.27m 1.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack